The Transplant Programme at Indraprastha Apollo Hospitals offers evaluation, surgery and lifelong follow-up for people whose organs or bone marrow have failed or are failing. It provides kidney and liver transplantation from living and deceased donors, along with bone marrow and stem cell transplantation, and other organ programmes where approved.
A transplant replaces a severely damaged organ with a healthy one from a donor, or restores the blood-forming system with healthy stem cells. For suitable patients, it can offer better quality of life and longer survival than continuing treatments such as dialysis. Not everyone is a candidate, and the decision depends on careful medical, surgical and psychological assessment of both recipient and donor.
Transplantation at the hospital is carried out under the Transplantation of Human Organs and Tissues Act, 1994 and its rules, which govern donor eligibility, consent and approvals. Transplant surgeons, physicians, anaesthesiologists, intensivists, transplant coordinators and counsellors guide patients and families through each stage, from evaluation to long-term care.
Upandikizaji Wetu KRA
The team includes transplant surgeons, hepatologists, nephrologists, cardiologists, haemato-oncologists, transplant anaesthesiologists and intensivists, supported by transplant coordinators, immunology laboratory specialists, infectious disease physicians, dietitians, psychologists and social workers. Each case is reviewed by a multidisciplinary transplant committee before listing or surgery, so that recipient and donor safety are both considered.Our specialists include:
A transplant is considered when an organ has failed or is close to failing and other treatments can no longer maintain health or life. The underlying cause also affects suitability and timing.
- Masharti ya Figo
- Masharti ya Ini
- Masharti ya Moyo na Mapafu
- Matatizo ya Damu
End-stage kidney disease - Permanent loss of kidney function, most often due to diabetes, high blood pressure, glomerulonephritis or polycystic kidney disease. Without dialysis or a transplant, waste and fluid build up in the body, causing breathlessness, swelling, nausea and confusion. Transplantation before dialysis becomes necessary may be possible for some patients with a suitable living donor.
- Cirrhosis and end-stage liver disease - Advanced scarring of the liver caused by alcohol, hepatitis B or C, fatty liver disease or autoimmune conditions. Complications include fluid in the abdomen, bleeding from swollen veins, confusion and jaundice. A severity score helps doctors judge when a transplant is needed.
- Acute liver failure - A sudden loss of liver function, sometimes caused by viral hepatitis or medicine overdose, which can become life-threatening within days and may need urgent transplantation.
- Liver cancer - Selected patients with hepatocellular carcinoma confined within defined size and number limits may benefit from transplantation, which removes both the tumour and the diseased liver.
- Childhood liver diseases - Biliary atresia, in which bile ducts are blocked or absent from birth, and certain inherited metabolic disorders are common reasons for liver transplantation in children.
- Kushindwa kwa moyo kwa hatua ya mwisho. Severe weakening of the heart muscle from cardiomyopathy, coronary artery disease or other causes, with breathlessness at rest and repeated hospital admissions despite optimal treatment.
- End-stage lung disease. Advanced interstitial lung disease, COPD or pulmonary hypertension that causes severe breathlessness and dependence on oxygen.
- Blood cancers - Leukaemia, lymphoma and multiple myeloma may be treated with high-dose therapy followed by stem cell transplantation, depending on the type, stage and response to earlier treatment.
- Bone marrow failure and inherited blood disorders - Aplastic anaemia, in which the bone marrow stops producing enough blood cells, and thalassaemia major, an inherited condition requiring regular transfusions, may be treated with an allogeneic stem cell transplant.
Transplant surgery is planned around the organ involved, the type of donor and the recipient's condition. Treatment plans vary by patient and are decided after evaluation by the transplant team.
- Kupandikiza figo
- Upandaji wa ini
- Kupandikiza Moyo
- Uboho na Uhamisho wa Seli Shina
- Mara Baada ya Upasuaji
- Dawa za Kuzuia Kukataliwa
- Ufuatiliaji wa muda mrefu
The donor kidney is placed in the lower abdomen and connected to the recipient's blood vessels and bladder; the patient's own kidneys are usually left in place. Living donor kidneys are often removed through keyhole surgery (laparoscopic donor nephrectomy), which generally allows a quicker recovery for the donor. ABO-incompatible transplants, where donor and recipient blood groups differ, use special treatment before surgery to lower antibody levels.
In a living donor liver transplant, a portion of the donor's liver is removed and transplanted; both the donor's remaining liver and the transplanted portion regrow towards normal size over the following weeks to months. In a deceased donor transplant, the recipient receives a whole liver or, in some cases, a split liver shared between two recipients.
The diseased heart is replaced with a healthy donor heart from a brain-stem dead donor, matched for blood group and body size. Some patients may need mechanical heart support while waiting.
The patient receives high-dose chemotherapy, sometimes with radiation, followed by an infusion of stem cells through a vein, similar to a blood transfusion. Patients stay in a protected unit until new blood cells begin to grow, usually over two to four weeks.
Recipients are monitored in a transplant intensive care unit and then a dedicated ward, with close checks of organ function, fluid balance and infection signs. Living donors receive separate post-operative care and follow-up.
All organ recipients need lifelong immunosuppressive medicines to prevent the body from rejecting the new organ. These must be taken exactly as prescribed, with regular blood tests to adjust doses and check for side effects such as infection, kidney effects, diabetes or high blood pressure.
Follow-up visits are frequent in the first months and then gradually spaced out. Recipients are advised on infection prevention, vaccinations, diet, sun protection and cancer screening. Living donors are followed up regularly to monitor their own health.
These facilities support safe transplantation and recovery; outcomes depend on the recipient's condition, donor factors and lifelong adherence to follow-up care.
- Dedicated transplant operating theatres
- Kupandikiza ICU
- HLA and transplant immunology laboratory
- Kitengo cha kupandikiza uboho chenye vyumba vilivyochujwa HEPA
- Laparoscopic and robotic donor surgery
- Advanced imaging and volumetry
- Ufuatiliaji wa dawa za matibabu
- Apheresis services
- Transplant coordination office
equipped for complex, lengthy procedures with simultaneous donor and recipient surgery.
intensive care with infection control measures designed for patients on immunosuppression.
tissue typing, antibody screening and crossmatch testing to assess compatibility and rejection risk.
protected rooms that reduce exposure to airborne infections when immunity is very low.
minimally invasive techniques for living kidney donors and selected liver donors.
CT and MRI planning of donor and recipient anatomy.
blood tests to measure anti-rejection medicine levels and fine-tune doses.
for stem cell collection and antibody removal in ABO-incompatible transplants.
manages legal documentation, approvals, waiting list registration and liaison with organ allocation bodies.
The hospital performs kidney and liver transplants from living and deceased donors, and bone marrow and stem cell transplants for selected blood disorders and cancers. Heart, lung, pancreas and paediatric transplant services may be available through specialised teams. Each patient is evaluated individually to decide suitability.
Useful points include an established transplant programme registered under Indian transplant law, experienced transplant surgeons and physicians, a dedicated transplant ICU, an HLA laboratory, infection control expertise, independent donor evaluation and organised long-term follow-up. Clear guidance on legal documentation and costs also helps families plan.
Living donors are usually close relatives such as a spouse, parent, child, sibling, grandparent or grandchild. Other donors need approval from an Authorisation Committee under the Transplantation of Human Organs and Tissues Act. Donors must be adults in good health, fully informed and donating voluntarily, without any payment or pressure.
Living donation is major surgery and carries risks, including bleeding, infection and, rarely, more serious complications. Donors are evaluated thoroughly to ensure they can donate safely, and most return to normal activities within weeks. Long-term follow-up is recommended to monitor blood pressure and organ function. Donors may withdraw consent at any time before surgery.
For kidney transplants, ABO-incompatible transplantation may be possible using treatments that lower the recipient's antibodies before surgery. Another option is paired or swap donation, where two incompatible donor-recipient pairs exchange donors, subject to legal approval. The transplant team explains which options suit each situation.
Waiting times vary widely depending on the organ, blood group, medical urgency, body size and organ availability in the region. Organs are allocated through national and state allocation systems according to set criteria. Patients on the waiting list need regular reviews to stay medically ready and must remain reachable at all times.
The length of stay depends on the type of transplant and the patient's recovery. Kidney transplant recipients often stay for one to two weeks, liver transplant recipients for longer, and bone marrow transplant patients usually several weeks until their blood counts recover. Living donors typically go home within a week.
Yes. Organ transplant recipients need to take anti-rejection medicines every day for as long as the transplanted organ functions. Missing doses can lead to rejection. Regular blood tests monitor medicine levels and side effects. Some bone marrow transplant recipients may be able to stop immunosuppression after a period, depending on their recovery.
Rejection may cause no symptoms at first and is often detected through routine blood tests. Possible signs include fever, reduced urine output or swelling after kidney transplant, jaundice or dark urine after liver transplant, breathlessness after heart transplant, and general tiredness. Any such symptoms should be reported to the transplant team immediately.
Siblings are usually tested first, as they have the highest chance of being a full HLA match. If no matched sibling is available, the team may search unrelated donor registries or consider a half-matched (haploidentical) family donor such as a parent or child. For some conditions, the patient's own stem cells can be used.
The financial counselling and insurance teams can explain estimated costs, help with pre-authorisation for insurance and guide families on applicable government schemes. Coverage varies for donor surgery, the transplant procedure and lifelong medicines, so early discussion helps families plan.
Patients from Delhi, Noida, Gurugram, Ghaziabad, Faridabad and neighbouring states can contact the transplant coordination team through the hospital's official website or verified appointment services. Bring all medical records, recent test reports and details of potential donors to the first consultation.
